Countless people in official Washington use these four words, or some variation, to try to get conservatives to endorse bad policy.
American consumers deserve fair prices for our excellent health care. But lawmakers won’t deliver those prices by trying to control the market.
This is not a government agency sharing risk, it’s a government agency assuming virtually all of the risk associated with the higher premium costs due to the rebate rule. In other words, a bailout.
While such costs represent a small fraction of overall spending on health care, several dynamics help the prescription drug issue gain disproportionate attention.
Here’s a solution: stop focusing on trying to control prescription drug prices, and start paying attention to who’s paying them.
In fact, Sen. Bernie Sanders is one of the most blatantly dishonest politicians on either side of the aisle, particularly on health care.
While the public hold little sympathy for Big Pharma, when the drug industry suffers, people suffer. And when Big Pharma wins, people win.
On Wednesday, a Senate committee will hold a hearing on President Trump’s appointment of Dr. Scott Gottlieb as commissioner of the Food and Drug Administration.
Watch out for five misguided attacks to persuade the public that government intervention in the pharmaceutical industry is necessary. Actually, it will make things worse.
- Trump’s Approval Is Spiking, And The Left Can’t Stand ItPresident Trump has stepped up his game in response to continue reading >
- The Scientist Whose Doomsday Pandemic Model Predicted Armageddon Just Walked Back The Apocalyptic PredictionsAfter both the U.S. and U.K. governments effectively shcontinue reading >
- Inaccurate Virus Models Are Panicking Officials Into Ill-Advised LockdownsHow a handful of Democratic activists created alarming,continue reading >